Fraunhofer-Institut für Zelltherapie und Immunologie (IZI)

Research facility


Location: Leipzig, Germany (DE) DE

ISNI: 0000000404943022

ROR: https://ror.org/04x45f476

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2 (2024) Wagner J, Müller-Schmucker S, Wang W, Arnold P, Uhlig N, Issmail L, Eberlein V, et al. Journal article Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model (2024) Stahl-Hennig C, Peter AS, Cordsmeier A, Stolte-Leeb N, Vestweber R, Socher E, Merida SA, et al. Journal article Identification of isoaspartate-modified transthyretin as potential target for selective immunotherapy of transthyretin amyloidosis (2024) Köppen J, Kleinschmidt M, Morawski M, Rahfeld JU, Wermann M, Cynis H, Hegenbart U, et al. Journal article A lipid membrane supported on an artificial extracellular matrix made of polyelectrolyte multilayers: towards nanoarchitectonics at the cellular interface (2022) Vikulina A, Wulf A, Guday G, Fakhrullin R, Volodkin D Journal article Alpha synuclein processing by MMP-3 – implications for synucleinopathies (2022) Bluhm A, Schrempel S, Moceri S, Stieler J, Feja M, Schilling S, Schulze A, et al. Journal article Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunization (2022) Lapuente D, Fuchs J, Willar J, Antao A, Eberlein V, Uhlig N, Issmail L, et al. Conference contribution Immunohistochemical Demonstration of the pGlu79 alpha-Synuclein Fragment in Alzheimer's Disease and Its Tg2576 Mouse Model (2022) Bluhm A, Schrempel S, Schilling S, von Hörsten S, Schulze A, Rossner S, Hartlage-Ruebsamen M Journal article Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside? (2022) Guedan S, Luu M, Ammar D, Barbao P, Bonini C, Bousso P, Buchholz CJ, et al. Journal article, Review article Time to evolve: predicting engineered T cell-associated toxicity with next-generation models (2022) Donnadieu E, Luu M, Alb M, Anliker B, Arcangeli S, Bonini C, De Angelis B, et al. Journal article, Review article MyoBio: An automated bioreactor system technology for standardized perfusion-decellularization of whole skeletal muscle (2022) Ritter P, Cai A, Reischl B, Fiedler M, Prölß G, Frie B, Kretzschmar E, et al. Journal article, Original article